glp-1 source GLP-1 SOS™ Digestive Support for

What the research shows: In the landmark STEP clinical trials, patients taking semaglutide lost an average of 15% of their body weight over 68 weeks

Available at: Accessed December 10th Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L

In vitro receptor agonism at Y1-R, Y2-R, and GLP-1R H188 virally transduced HEK293 cells stably expressing human GLP-1R were obtained from Novo Nordisk A/S for use in FRET assays

The capacity of GLP-1 RAs to decelerate gastric emptying to levels indicative of gastroparesis raises concerns regarding potential intestinal obstruction and perioperative aspiration risk

I felt like I needed to make a change, but due to severe arthritis from years of standing while teaching, I couldnt engage in physical exercise